Introduction
Transforming growth factor-β 1 (TGF-β 1), belongs to a family of five polypeptides that exert complex effects on organ development, cell growth and differentiation, expression of extracellular matrix, angiogenesis and tissue repair. It has been implicated as an important factor for the development of renal fibrosis, glomerulosclerosis and tubular atrophy associated with salt loading, and it has been shown to be overexpressed in salt-loaded rats ( 1 ) . Renal salt overload inhibits renin release from the juxtaglomerular apparatus and reduces circulating angiotensin II (Ang II). However, experimental studies have demonstrated that, despite the inhibition of the renin-angiotensin system (RAS) by salt-overload, local Ang II may be stimulated ( 2 ) . Ang II, in addition to playing a critical role on blood pressure (BP) and hydrosaline balance regulation in the kidney, exerts direct effects at the cellular level, promoting cell growth and differentiation, and is a mediator of oxidative stress, inflammation and fibrosis ( 3 , 4 ) . Nuclear factor-κ B (NF-κ B) and AP-1 are the major nuclear transcription factors responsible for the regulation of several inflammatory genes in response to Ang II, such as those for cytokines, chemokines, and adhesion molecules ( 2 ) . In vitro , increased activation of NF-κ B in response to Ang II has been shown in several cell types, including vascular smooth muscle cells and endothelial, glomerular, tubular and mononuclear cells ( 2 ) . In vivo , increased NF-κ B activity and expression are shown in the vasculature, heart, and kidney of Ang II-infused rats ( 5 ) . In addition, there exists a close interaction between the RAS and TGF-β 1 systems. Recent data provide compelling evidence that other components of the RAS, including Ang III, renin and aldosterone, also activate the TGF-β 1 system ( 6 ). Ang II-stimulated cells express more TGF-β 1 mRNA and produce active TGF-β 1. Ang II also enhances post-transcriptional expression of TGF-β 1 protein ( 7 , 8 ) . More recently, it has been shown that TGF-β 1 stimulates angiotensinogen gene expression, and this stimulation is mediated by the generation of reactive oxygen species (ROS), suggesting that Ang II and TGF-β 1 may form a positive feedback loop to enhance their respective gene expressions, leading to renal injury ( 9 ) . α -Smooth muscle actin ( α -SMA) is a smooth muscle cell cytoskeleton protein and a marker of trans-differentiation from fibroblast to myofibroblast. In the normal kidney, α -SMA is present only in the vascular wall, whereas during the fibrotic process, cells expressing α -SMA are detected in the renal interstitium. α -SMA is strongly upregulated by TGF-β 1, which plays a role in the transformation of fibroblasts into myofibroblasts in the tubulointerstitial area. In this regard, previous studies from our laboratory showed that an acute salt loading in normal rats increased intrarenal Ang II, TGF-β 1 and α -SMA immunoexpression, even before structural and functional changes appeared, and these upregulations were correlated with greater sodium tubular reabsorption ( 10 ) . Considering that Ang II is able to enhance intrarenal TGF-β 1 by a direct action or indirectly through an increase in sodium transport, it is possible to speculate that co-infusion of low-doses of exogenous Ang II together with hypertonic saline solution could exacerbate immunoexpression of the profibrogenic cytokine TGF-β 1.
Methods
Male Sprague-Dawley rats (10-12 weeks old; 270-350 g body weight) were used. Animals were housed at a controlled temperature (23 ± 2 ° C) and exposed to a daily 12-h light-dark cycle (lights on 7:00 AM to 7:00 PM) with free access to tap water and standard rat chow. On the day of the experiment, rats were anesthetized with 10% urethane ( for urine collection using a PE-75 cannula.
All infusions were carried out at the same rate of 0.04 mL min Urine and blood samples were collected at 30 and 60 min, respectively, for sodium, potassium and creatinine measurements. Mean arterial BP was monitored continuously throughout the procedure.
Urine and Blood Measurements
Urine and plasma sodium, potassium and creatinine were measured by standard methods. Sodium fractional excretion and creatinine clearance were calculated according to the standard formulas. Creatinine clearance was assessed in order to evaluate the glomerular filtration rate (GFR). Urinary flow was expressed as μ L min − 1 ; plasma and urinary sodium and potassium as μ Eq L − 1 ; sodium and potassium urinary excretion as μ mol min −1 ; and GFR as mL min −1 .
Kidney Processing for Histological Examination
At the end of the infusion period, the left kidney was perfused with ISS through the abdominal aorta until the blood was washed out and the parenchyma had a pale appearance. The kidney was then rapidly excised, decapsulated, longitudinally cut and harvested for light microscopy and immunohistochemical studies. Tissues were fixed in phosphate-buffered 10% formaldehyde (pH 7.2) and embedded in paraffin using conventional histological techniques. Three μm-thick sections were cut and stained with hematoxylin-eosin for light microscopy. For immunohistochemistry, sections were deparaffined and rehydrated, and endogenous peroxidase activity was blocked by treatment with 0.5% H2O2 in methanol for 20 min. Local TGF-β1 was detected using the following antibodies: mouse anti-TGF-β1 (Santa Cruz Biotechnology Inc., Santa Cruz, USA; dilution: 1:200), mouse anti-α SMA (Sigma Chemical Co., St. Louis, USA; dilution: 1:150) and mouse anti-NF-κB p65 (Santa Cruz Biotechnology Inc.; dilution: 1:150). Immunostaining was carried out by means of a commercial modified avidin-biotin-peroxidase complex technique (Vectastain ABC Universal Elite Kit; Vector Laboratories, Burlingame, USA) and counterstained with hematoxylin. The samples were handled as previously described (11) .
Histological sections were observed using a Nikon E400 
Fig. 1. A: Blood pressure (BP). B: Glomerular filtration rate (GFR). C: Sodium tubular reabsorption (TRNa). D: Sodium filtered load (FLNa

Statistical Analysis
Results from urine and blood measurements and mean arterial pressure levels are expressed as the means±SEM. The Gaussian distribution was evaluated by the Kolmogorov and Smirnov method, and comparisons among groups were carried out using ANOVA followed by the Newman-Keuls test. Statistical analysis for those parameters with non-Gaussian distribution (such as histological data) was performed by the 
Results
To assess the effects of sodium overload and exogenous Ang II infusion on BP and glomerular function, BP was measured throughout the experimental period, and urinary flow, plasma and urinary sodium and potassium, and creatinine levels were determined. Table 1 summarizes the plasma sodium concentration, urinary sodium and potassium excretion, and urinary flow at the end of the study. The plasma sodium concentration increased in a sodium concentration-dependent manner, independently of the presence or absence of exogenous Ang II. Urinary flow increased in a sodium concentration-dependent manner. The Ang 5 plus salt overload group showed a decrease in diuresis as compared with the salt overload groups without Ang II. Urinary flow and urinary sodium excretion showed a similar behavior. Urinary potassium excretion was not significantly different among the groups, with the exception of a significant decrease in the Ang 5-Na 0.5 group. Figure 1 shows the results for BP, GFR, sodium tubular reabsorption (TR Na ) and sodium filtered load (FL Na ). The results shown are the values measured at the end of the study. BP increased only in groups Ang 5-Na 1.0 and Ang 5-Na 1.5 compared to Na 1.0 and Na 1.5, respectively (Fig. 1A) . Infusion of Ang 0.1 or Ang 5 alone did not elevate BP compared with the control group infused with ISS.
GFR increased in the Ang 5 group compared to the Ang 0.1 (Fig. 1B) .
TR Na (Fig. 1C ) and FL Na (Fig. 1D ) exhibited a very similar response pattern to that of GFR, being significantly higher in the Ang 5 group compared to the Ang 0.1 group, and in the Ang 0.1-Na 0.5 and Ang 0.1-Na 1.0 groups compared with Na 0.5 and Na 1.0, respectively. Additionally, the Ang 5-Na 0.5 group showed a greater TR Na than the Na 0.5 group. Histological examination did not reveal morphological damage in the glomeruli and tubules in any group (data not shown). Figure 2 shows the TGF-β 1 immunostaining in the renal cortex ( Fig. 2A ) and the medulla (Fig. 2B) . Panel A shows staining in the renal cortex of rats infused with Ang II (0.1 and 5 μ g kg − 1 h −1 ) with or without HSS. In glomeruli, TGF-β1 was markedly elevated in the group receiving Ang 5 alone compared to the C group and in the 3 groups co-infused with Ang 5 and sodium compared with the 3 HSS groups. In cortical tubules, all groups with Ang II (0.1 and 5 μg kg −1 h −1 ) and HSS exacerbated TGF-β1 immunostaining in a sodium concentration-dependent manner compared to those with HSS alone, except in the case of the Ang 0.1-Na 1.5 group vs. the Na 1.5 group. In medullary tubules, only the group Ang 5-Na 0.5 showed increased TGF-β1 immunostaining compared to the group Na 0.5. In vessels, only the highest Ang II dose induced stimulation of TGF-β1 expression, and this stimulation was also sodium-dependent. In medullary tubules (Fig. 2B) , TGF-β1 immunostaining was increased in the Ang 5-Na 0.5 group compared to the Na 0.5 group. Furthermore, the Ang 5-Na 1.5 group showed a decrease in TGF-β1 immunostaining compared to the Na 1.5 group. In medullary vessels, TGF-β1 was markedly elevated in the Ang 5, Ang 5-Na 0.5, Ang 5-Na 1.0, and Ang 0.1-Na 1.0 groups compared to both the C and HSS groups. In addition, the Ang 0.1-Na 1.5 and Ang 5-Na 1.5 groups showed a decreased response, compared to the Na 1.5 group. TGF-β1 staining was present in the glomerular mesangium, glomerular capillary endothelium and vascular endothelium. TGF-β1 staining was very scarce in podocytes, especially in the Na 0.5 group. Tubular cytoplasmic staining was observed in the collecting and distal tubules. Positive expression in proximal tubules was present only in the Ang 5 and Ang 0.1 groups HSS. α -SMA immunostaining in the cortex and medulla increased in the groups receiving Ang alone or in those receiving both Ang and Na in a sodium concentration-dependent manner. Figure 5 shows NF-κB immunostaining in the renal cortex and medulla of rats infused with Ang II (0.1 and 5 μg kg
Fig. 5. NF-κ B. Immunostaining in the renal cortex (A) and medulla (B). A: Quantitative representation of positive staining in the glomeruli, expressed as the number of positive glomeruli on a counted total of 50 glomeruli in each slice ± SD). C (control), Na
with or without HSS. Positive immunostaining for NF-κB was seen in the nuclei and cytoplasm of tubular and glomerular cells. In the glomeruli, NF-κB staining was increased in the Ang group compared with the C group and in the Ang-Na groups compared with the HSS groups, with the exception of the Ang 0.1-Na 1.5 group. In the cortical tubules (Fig. 5A) , NF-κB immunostaining increased in the Ang groups compared to the C group and in the Ang 0.1-Na 0.5 and Ang 0.1-Na 1.0 groups compared to Na 0.5 group and in the Ang 5-Na 1.0 and Ang 5-Na 1.0 compared to the Na 1.0 group, with the exception of the Ang 0.1-Na 1.5 and Ang 5-Na 1.5 groups. In the medullary tubules (Fig. 5B) , NF-κB was higher in the Ang and Ang-Na groups than in either the C or HSS group.
Discussion
In this study, acute administration of low doses of Ang II further enhanced the intrarenal TGF-β1, α-SMA and NF-κB expression in rats submitted to sodium overload, independently from changes in BP. The low Ang II dose, administered alone or together with hypertonic HSS, did not raise BP, but increased TGF-β1 expression in the renal cortex as well as the renal medulla. However, the high Ang II dose administered alone or together with hypertonic Na 0.5 did not alter BP, but increased TGF-β1 expression as well. BP was only elevated by the Ang 5 dose when it was simultaneously co-infused with high sodium overload (Na 1.0 and 1.5), showing a progressive enhancement of TGF-β1 expression in the cortex but not in the renal medulla. Thus our results demonstrated the absence of a correlation between BP levels and TGF-β1 expression in groups with lower doses of Ang II, suggesting that TGF-β1 expression may be regulated by other factors. In the present study, GFR was increased or unchanged, rather than decreased. Co-infusion of Ang II and ISS augmented GFR in the Ang 5 group compared to the Ang 0.1 group. It is known that the Ang II at a low concentration (10 −12 mol L −1 ) is able to increase sodium transport at the macula densa, leading to a decrease in GFR, and then a decrease in urine flow velocity (UV) and sodium urinary excretion (UNaV). Nevertheless, when Ang 5 was infused, GFR and TRNa increased but UV and UNaV were similar to those in the control group. Moreover, a lower Ang II dose, co-infused together with HSS (Na 0.5 mol L −1 or Na 1.0 mol L −1 ), was able to increase GFR and sodium tubular reabsorption, whereas the higher Ang II dose co-infused with the same HSS did not change GFR, although it reduced the urinary sodium excretion. These data suggest that the early high GFR could be necessary to exert a natriuretic influence, in order to maintain normal BP and sodium balance by counteracting sodiumretaining factors such as Ang II. Although this may serve to maintain sodium balance in the short term, using this mechanism over the long-term or at higher Ang doses would clearly be maladaptive by contributing to progressive glomerular injury. Thus, the decline of GFR to progressively more normal levels is shown to be a renal function change for the purpose of retaining sodium and thereby increasing BP, as we observed in the Ang 5-Na 1.0 and Ang 5-Na 1.5 groups. Therefore, the increase in TGF-β1 expression in the cortical tubules induced by both doses of Ang II alone and by both doses of Ang II with Na 1.0 and Na 1.5 could be related to the fact that both GFR and sodium tubular transport were increased. The present data suggest that increased activation of TGF-β1 in the kidney could be the result of augmented GFR and/or sodium tubular reabsorption when low doses of Ang II are infused simultaneously with sodium overload. Accordingly, it has been demonstrated that an increment in tubular sodium concentration or sodium flow leads to a greater sodium transport. This effect has been associated with enhanced production of superoxide anion and decreased production of nitric oxide, and these changes are dependent on oxygen utilization (12) . Since either a reduction in nitric oxide or an increase of superoxide anion could regulate TGF-β1 expression, nitric oxide provides an essential inhibitory feedback mechanism that modulates TGF-β1 production. Glomerular and vascular ring preparations incubated with L-NAME, a NOS3 inhibitor, have been shown to produce increased amounts of TGF-β1, while incubation with a nitric oxide donor decreases TGF-β1 production (1). Additionally, enhanced superoxide anion is known to act as a second messenger in the activation of transcription nuclear factors NF-κB and activator protein-1 (AP-1), which plays a key role in the generation of proinflammatory cytokines, chemokines and growth factors such as TGF-β1 (13) . In addition to the sodium-retaining effect, Ang II activity has other potential consequences, including production of superoxide anion by NAD(P)H oxidase activation, which is mainly mediated via Ang II type 1 (AT1) receptors (14) . Therefore, considering the extensive localization of AT1 receptors in the luminal and basolateral membranes of proximal and distal nephron segments (5), Ang II can regulate the activation of transcriptional factors through superoxide anion produced directly by NAD(P)H oxidase-activation or through superooxide anion produced indirectly through increased sodium transport (15) . In the present study, the higher NF-κB expressions observed in the glomeruli and tubules of the Ang-Na groups compared to the Na groups were independent of the BP level.
A comparison of the NF-κB and TGF-β1 expression profiles found in our study suggests that the greater TGF-β1 expression in the glomeruli and tubules in the Ang-Na groups may have been due to the activation of NF-κB, except in the case of the groups that developed arterial hypertension, in which some other mechanism of activation could be present.
In the present study, we observed a higher rate of positive staining for α-SMA in the renal peritubular interstitium of the Ang and Ang-Na groups than in that of the Na groups. The accumulation of myofibroblasts, which express α-SMA and thereby lead to extracellular matrix expansion, constitutes an early event in interstitial fibrogenesis. Since transformation of fibroblasts into myofibroblasts in the tubulointerstitial area is strongly up-regulated by TGF-β 1, it is not surprising that in our study intense staining of TGF-β 1 in the tubular epithelium coexisted with intense peritubular expression of α -SMA.
In the renal medulla, we observed a higher TGF-β 1 expression in the tubules and vessels from the Ang-Na groups, except in the Ang-Na 1.5 group, where TGF-β 1 expression was significantly decreased.
Interestingly, Ang II increased NF-κ B expression independently of hemodynamic changes, GFR or the sodium concentration infused.
Ang II is involved in tubulointerstitial fibrosis via its nonhemodynamic-effects on renal function. Ang II stimulates cellular hypertrophy of proximal tubular cells dependent on TGF-β 1 expression. In contrast to its effects on proximal tubular cells, Ang II stimulates proliferation and increase of TGF-β 1 mRNA expression in rat glomeruli endothelial cells and of more distal nephron segments, such as cells isolated from the thick ascending limb of Henle's loop. Among the downstream targets of TGF-β 1 is hSGK1, a volume regulated serine/threonine kinase cell. TGF-β 1 upregulates hSGK1, which leads to marked stimulation of the epithelial sodium channel ENaC and the Na/K/2Cl cotransporter ( 16 ) . The enhanced expression of hSGK1 could favor renal sodium retention, enhanced energy consumption and hyperfiltration. Any increase of cell volume mediated by hSGK1-induced Na entry would impair matrix protein degradation and thus enhance the net deposition of matrix protein. In addition, Ang II could induce apoptosis of renal cells under certain conditions. Taking all these factors together, it could be suggested that the observation of a decrease in TGF-β 1 expression in the medulla but not the cortex in the Ang-Na 1.5 groups was attributable to an adaptive process to protect the renal medulla from sodium overload.
In summary, Ang II doses to low to induce hypertension exacerbated intrarenal TGF-β 1, α -SMA and NF-κ B expression response to acute sodium overload, even before any increase in arterial pressure or development of glomerular functional alterations. These findings demonstrate the presence of a close relationship between Ang II-salt excess and renal inflammation and fibrosis. Moreover, this interaction could stimulate the expression of profibrogenic cytokines independently of BP levels.
